Schering-Plough Reports Financial Results for 2009 First Quarter
... (23%) INTEGRILIN 76 74 3% REBETOL 66 59 12% caelyx 61 74 (18%) INTRON A 54 55 (3%) PROVENTIL / ALBUTER...Schering-Plough Reports Financial Results for Third Quarter of 2008
...LARITIN RX 87 83 5% 326 297 10% INTEGRILIN 84 78 7% 236 241 (2%) caelyx 80 64 24% 232 191 22% ZEMURON c/ 72 - - 202 - - AVELOX...Schering-Plough Reports Financial Results for Third Quarter of 2007
... INTEGRILIN 78 82 (4%) 241 244 (1%) AVELOX 78 63 24% 269 201 34% caelyx 64 52 23% 191 156 22% INTRON A 61 57 7% 176 180 (2%) REBETOL ...Schering-Plough Reports Financial Results for 2009 Second Quarter
...RILIN 73 78 (7%) 149 152 (2%) REBETOL 67 70 (4%) 134 130 3% caelyx 68 78 (14%) 128 152 (16%) INTRON 67 61 10% 121 116 4% P...Schering-Plough Reports Financial Results for First Quarter of 2008
... NUVARING c/ 96 - N/M INTEGRILIN 74 84 (13%) caelyx 74 62 20% REMERON c/ 68 - N/M ZEMURON c/ ...Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
...26% INTEGRILIN 91 85 7% 332 329 1% REBETOL 71 75 (6%) 277 311 (11%) caelyx 66 49 33% 257 206 25% INTRON A 57 57 - 233 237 (2%) SUBUTEX / ...